Jeffrey W. Prichard
- Co-authors
- Fan LinKai ZhangRobert BrownConrad SchuerchAlbert QuieryHaiyan LiuJianhui ShiPing L. Zhang
- Topics
- Esophageal Cancer Research and Treatment (4 papers)Sarcoma Diagnosis and Treatment (4 papers)Renal Diseases and Glomerulopathies (3 papers)
- Partner nations
- United StatesIrelandIsrael
In The Last Decade
Jeffrey W. Prichard
39 papers receiving 893 citations
Peers
Comparison fields: 5 of 102
- Pulmonary and Respiratory Medicine 296
- Oncology 291
- Molecular Biology 217
- Surgery 214
- Cancer Research 146
Countries citing papers authored by Jeffrey W. Prichard
This map shows the geographic impact of Jeffrey W. Prichard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey W. Prichard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey W. Prichard more than expected).
Fields of papers citing papers by Jeffrey W. Prichard
This network shows the impact of papers produced by Jeffrey W. Prichard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey W. Prichard. The network helps show where Jeffrey W. Prichard may publish in the future.
Co-authorship network of co-authors of Jeffrey W. Prichard
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey W. Prichard. A scholar is included among the top collaborators of Jeffrey W. Prichard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey W. Prichard. Jeffrey W. Prichard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 31 | |
| 3 | 32 | |
| 4 | 44 | |
| 5 | 21 | |
| 6 | 29 | |
| 7 | 45 | |
| 8 | 23 | |
| 9 | 4 | |
| 10 | 3 | |
| 11 | Unusual warm autoimmune hemolytic anemia in non-alcoholic steatohepatitis. | 3 |
| 12 | 16 | |
| 13 | Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates. | 22 |
| 14 | 48 | |
| 15 | 7 | |
| 16 | 31 | |
| 17 | 11 | |
| 18 | 15 | |
| 19 | 85 | |
| 20 | 22 |
About Jeffrey W. Prichard
Jeffrey W. Prichard is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Pharmacy, having authored 40 papers that have together received 927 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Oncology (291 citations), Cancer Research (146 citations) and Pulmonary and Respiratory Medicine (296 citations). Jeffrey W. Prichard has collaborated with scholars based in United States, Ireland and Israel. Frequent co-authors include Fan Lin, Kai Zhang, Robert Brown, Conrad Schuerch, Albert Quiery, Haiyan Liu, Jianhui Shi, Ping L. Zhang, Peter Olson and Mingyue Lun. Their work appears in journals such as Oncogene, Arteriosclerosis Thrombosis and Vascular Biology and Gastrointestinal Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.